GW5074 Increases Microglial Phagocytic Activities: Potential Therapeutic Direction for Alzheimer’s Disease is a research paper published in Frontiers in Cellular Neuroscience (2022). On theSindex it has a DataRank of 0.425. It has been cited 16 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.425
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institutes of Health
Grant: RF1AG058852
National Institutes of Health
Grant: R01AG17917
National Institutes of Health
Grant: U01AG61356
National Institutes of Health
Grant: T32AI148099
NIA NIH HHS
Grant: R01 AG015819
NIA NIH HHS
Grant: R01 AG017917
NIA NIH HHS
Grant: P30 AG072975
NCRR NIH HHS
Grant: S10 RR027050
NIA NIH HHS
Grant: P30 AG010161
NIA NIH HHS
Grant: R01 AG043617
National Institutes of Health
Grant: 5R01AG017917-20
Epidemiologic Study of Neural Reserve and Neurobiology of Aging
National Institutes of Health
Grant: 3U01AG061356-02S1
Multi-omic network-directed proteoform discovery, dissection and functional validation to prioritize novel AD therapeutic targets
National Institutes of Health
Grant: 1S10RR027050-01A1
Becton Dickinson LSR II Analytical Flow Cytometer
National Institutes of Health
Grant: 1RF1AG058852-01
Convergence of myeloid susceptibility protein function in Alzheimer's disease
National Institutes of Health
Grant: 5T32AI148099-04
Training in Translational Immunology Research
Pfizer
Alzheimer's Drug Discovery Foundation
FWCI
1.76
Citation Percentile
0.9%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals
Additional file 1 of Advanced patient-specific microglia cell models for pre-clinical studies in Alzheimer’s disease
Additional file 1 of Advanced patient-specific microglia cell models for pre-clinical studies in Alzheimer’s disease
Additional file 6 of Advanced patient-specific microglia cell models for pre-clinical studies in Alzheimer’s disease
Additional file 6 of Advanced patient-specific microglia cell models for pre-clinical studies in Alzheimer’s disease
Additional file 7 of Advanced patient-specific microglia cell models for pre-clinical studies in Alzheimer’s disease
Additional file 7 of Advanced patient-specific microglia cell models for pre-clinical studies in Alzheimer’s disease
Additional file 4 of Advanced patient-specific microglia cell models for pre-clinical studies in Alzheimer’s disease
Additional file 4 of Advanced patient-specific microglia cell models for pre-clinical studies in Alzheimer’s disease
Additional file 5 of Advanced patient-specific microglia cell models for pre-clinical studies in Alzheimer’s disease
Additional file 5 of Advanced patient-specific microglia cell models for pre-clinical studies in Alzheimer’s disease
Additional file 2 of Advanced patient-specific microglia cell models for pre-clinical studies in Alzheimer’s disease
Additional file 3 of Advanced patient-specific microglia cell models for pre-clinical studies in Alzheimer’s disease
Additional file 2 of Advanced patient-specific microglia cell models for pre-clinical studies in Alzheimer’s disease
Additional file 3 of Advanced patient-specific microglia cell models for pre-clinical studies in Alzheimer’s disease